General Inception

About The Fund

General Inception is an investment fund focusing on the cutting-edge sectors of BioTech, DeepTech, and Pharmaceutical & Medicine. With a strategic emphasis on innovation and technology, they dedicate their investments to companies that show potential for significant advancements in these fields. They allocate funds to innovative ventures with a minimum investment threshold of $200,000 and a maximum limit of $500,000, with their ideal or 'sweet spot' investment being around $400,000. This indicates a focused approach to nurturing and supporting early-stage companies that align with their investment thesis. As specialists in the Pre-seed funding stage, General Inception is committed to identifying and empowering entrepreneurs who are at the very onset of their paths towards disrupting the market with breakthroughs in science and technology. They look for founding teams with strong scientific expertise and the ability to translate complex research into viable business models that can shape the future of their respective industries. General Inception leverages its resources and network to provide more than just capital; they partner in a way that facilitates strategic development, regulatory navigation, and market penetration for the startups they invest in. The fund's commitment to groundbreaking companies stems from a belief that the convergence of science and innovation has the power to address some of the most pressing global challenges and offer unprecedented improvements in health and society.